General
Preferred name
mardepodect
Synonyms
PF-2545920 ()
PF-02545920 ()
Mardepodect (hydrochloride) ()
PF-2545920 (hydrochloride) ()
Mardepodect (PF-2545920) ()
MP-10 ()
PF-2545920 ()
P&D ID
PD004447
CAS
1292799-56-4
1037309-45-7
898562-94-2
2070014-78-5
Tags
available
drug candidate
Drug indication
Huntington disease
Schizophrenia
Drug Status
investigational
Max Phase
Phase 2
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Mardepodect (PF-2545920) is a selective, orally active inhibitor of phosphodiesterase (PDE) 10A . Identified using structure-based drug design, the compound is optimised for selectivity, brain penetration and drug-like properties. PF-2545920 is the first PDE10A inhibitor identified as a clinical lead utilizing this mechanism for the treatment of schizophrenia. (GtoPdb)
DESCRIPTION PF-2545920 is a selective, orally active inhibitor of phosphodiesterase (PDE) 10A . Identified using structure-based drug design, the compound is optimised for selectivity, brain penetration and drug-like properties. Proposed INN is mardepodect. PF-2545920 is the first PDE10A inhibitor identified as a clinical lead utilizing this mechanism for the treatment of schizophrenia.
Cell lines
0
Organisms
1
Compound Sets
17
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
392.16
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
5
Ring Count
5
Aromatic Ring Count
5
cLogP
5.28
TPSA
52.83
Fraction CSP3
0.08
Chiral centers
0.0
Largest ring
6.0
QED
0.41
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Metabolic Enzyme/Protease
Target
PDE10A
Phosphodiesterase (PDE)
PDE
Member status
member
MOA
Phosphodiesterase 10A Inhibitors
phosphodiesterase inhibitor
Source data